Susquehanna International Group’s Tonix Pharmaceuticals TNXP Stock Holding History

Susquehanna International Group’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$521K	Sell	40,800 -12,500	-23%	-$161K	﹤0.01%	9835
2026 Q1	$733K	Buy	53,300 +29,900	+128%	+$460K	﹤0.01%	8699
2025 Q4	$366K	Buy	23,400 +1,800	+8%	+$33.2K	﹤0.01%	9489
2025 Q3	$522K	Buy	+21,600	New	+$802K	﹤0.01%	8838
2016 Q3	–	Hold	0	–	-$25K	–	9057
2016 Q2	–	Hold	0	–	–	–	8355
2016 Q1	–	Hold	0	–	–	–	8731
2015 Q4	–	Hold	0	–	–	–	5706
2015 Q3	–	Hold	0	–	–	–	9242
2015 Q2	–	Hold	0	–	–	–	9368
2015 Q1	–	Hold	0	–	–	–	8851
2014 Q4	–	Hold	0	–	-$185K	–	10101
2014 Q3	–	Hold	0	–	–	–	8750

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments Los Angeles, California $136M AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group's TNXP Position: Q2 2026 in Review

Susquehanna International Group increased its Tonix Pharmaceuticals (TNXP) stake by 45% in Q2 2026, buying an estimated $174K and bringing the position to 43,034 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #9695.

Susquehanna International Group first reported a position in TNXP in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.01M in Q1 2021. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

Susquehanna International Group held 43,034 shares of Tonix Pharmaceuticals worth $549K as of Q2 2026.
Susquehanna International Group bought 13,455 Tonix Pharmaceuticals shares in Q2 2026, an estimated $174K.
Tonix Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #9695 holding.
Susquehanna International Group first reported a position in Tonix Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
Susquehanna International Group's Tonix Pharmaceuticals position peaked at $1.01M in Q1 2021.
102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.